Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 130 (1), 159-165

Single, High-Dose Local Injection of bFGF Improves Thyroarytenoid Muscle Atrophy After Paralysis


Single, High-Dose Local Injection of bFGF Improves Thyroarytenoid Muscle Atrophy After Paralysis

Takao Goto et al. Laryngoscope.


Objectives/hypothesis: Unilateral vocal fold paralysis (UVFP) induces hoarseness due to progressive atrophy of the denervated thyroarytenoid (TA) muscle. Therefore, treatments aimed at regenerating the atrophied TA muscle are required. Basic fibroblast growth factor (bFGF) is involved in muscle development and regeneration. This study aimed to elucidate the effects of bFGF injection on atrophied TA muscle.

Study design: Animal research.

Methods: A recurrent laryngeal nerve-paralysis rat model was established, and low- (200 ng) or high-dose (2,000 ng) bFGF or saline (control) was injected into the TA muscle 28 days later. The larynges were excised on day 1, 3, 7, 14, and 28 after treatment. The cross-sectional area of the TA muscle in normal and paralyzed sides was compared, and the Ki67-positive (Ki67+ ) dividing cells, paired box 7-positive (Pax7+ ) satellite cells (SCs), and myogenic differentiation-positive (MyoD+ ) myoblasts were counted.

Results: The TA muscle area of animals administered high-dose bFGF increased with time and was significantly larger than that of the saline-injected controls 28 days after treatment (P < .05). The counts of Ki67+ and Pax7+ cells were the highest on day 1, whereas the MyoD+ myoblast count was highest on day 7. These results suggest that bFGF administration into the denervated TA muscles compensated for the atrophied TA muscles by inducing proliferation of SCs and their differentiation to myoblasts.

Conclusions: A single injection of high-dose bFGF augmented regeneration and differentiation of the atrophied TA muscle by enhancing proliferation and differentiation of muscle SCs, suggesting its possible clinical application in humans with UVFP.

Level of evidence: NA Laryngoscope, 130:159-165, 2020.

Keywords: Basic fibroblast growth factor; muscle satellite cells; myoblasts; regeneration; vocal fold paralysis.

Similar articles

See all similar articles



    1. Tamura E, Fukuda H, Tabata Y. Intracordal injection technique: materials and injection site. Tokai J Exp Clin Med 2008;33:119-123.
    1. Hess MM, Fleischer S. Laryngeal framework surgery: current strategies. Curr Opin Otolaryngol Head Neck Surg 2016;24:505-509.
    1. Crumley RL. Update: ansa cervicalis to recurrent laryngeal nerve anastomosis for unilateral laryngeal paralysis. Laryngoscope 1991;101(4 pt 1):384-387; discussion 388.
    1. Lorenz RR, Esclamado RM, Teker AM, et al. Ansa cervicalis-to-recurrent laryngeal nerve anastomosis for unilateral vocal fold paralysis: experience of a single institution. Ann Otol Rhinol Laryngol 2008;117:40-45.
    1. Yumoto E, Sanuki T, Toya Y, Kodama N, Kumai Y. Nerve-muscle pedicle flap implantation combined with arytenoid adduction. Arch Otolaryngol Head Neck Surg 2010;136:965-969.

LinkOut - more resources